免疫效应细胞相关的血液毒性:机制,临床表现和管理策略
Ofrat Beyar-Katz1, Kai Rejeski2, Roni Shouval3
1Department of Hematology and Bone Marrow Transplantation, Rambam Health Care Campus, Haifa, Israel; The Ruth and Bruce Rappaport Faculty of Medicine, Technion, Haifa. o_katz@rmc.gov.il.
Haematologica
|February 20, 2025
概括
免疫效应细胞相关的血液毒性 (ICAHT) 是CAR T细胞治疗的严重副作用,导致血细胞计数较低. 管理ICAHT是改善患者治疗结果和治疗可访问性的关键.
科学领域:
- 血液学 血液学 血液学
- 免疫治疗是一种免疫疗法.
- 在瘤学瘤学.
背景情况:
- 化学抗原受体 (CAR) T细胞疗法在治疗血液恶性瘤方面取得了重大进展.
- 免疫效应细胞相关的血液毒性 (ICAHT),以中性质衰竭,贫血和血栓细胞衰竭为特征,是主要的并发症.
- ICAHT增加了感染,输血依赖和死亡的风险,影响了患者的发病率和非复发死亡率.
研究的目的:
- 在CAR T细胞治疗中审查ICAHT的发病率,机制和风险因素.
- 讨论管理ICAHT的当前和新兴战略.
- 强调优化ICAHT管理对CAR T细胞疗法的有效性和可访问性的重要性.
主要方法:
- 关于CAR T细胞治疗和相关血液毒性的现有文献的综述.
- 分析导致ICAHT的因素,包括疾病负担,免疫状态和CAR T细胞产品特征.
- 讨论ICAHT分类和风险分层的标准化分级系统.
主要成果:
- ICAHT的发病率,机制和风险因素是复杂的,涉及患者和疗法特定的因素.
- 标准化的分级系统改善了ICAHT的分类和风险分层.
- 预防和治疗策略,包括生长因子和干细胞增强剂,可用于ICAHT管理.
结论:
- 优化ICAHT的管理对于改善CAR T细胞治疗中患者的治疗结果至关重要.
- 需要量身定制的干预措施来缓解血液毒性,而不会影响CAR T细胞的疗效.
- 改进ICAHT管理可以减少医疗保健的使用率,并提高CAR T细胞疗法可用于更广泛的适应症的可用性.
更多相关视频
06:08Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model
Published on: February 10, 2023
1.3K
12:40Preparation and Pathogen Inactivation of Double Dose Buffy Coat Platelet Products using the INTERCEPT Blood System
Published on: December 7, 2012
28.6K
相关概念视频
01:01Regulation of Hematopoietic Stem Cells
3.1K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.1K
01:27Cytotoxic T Cells-mediated Immune Response
830
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
830
02:45Blood Transfusion and Agglutination
10.7K
Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
10.7K
01:24Disorders of Hemostasis
686
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
686
01:28Role of Hematopoietic Growth Factors
1.2K
Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
Thrombopoietin (TPO), mainly released by the liver,...
1.2K
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
597
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
597